FDA grants emergency use authorization to J&J COVID-19 vaccine
MANILA, Philippines — Johnson & Johnson has secured an emergency use authorization (EUA) for its Janssen COVID-19 vaccine from the Food and Drug Administration (FDA), Secretary Carlito Galvez Jr., the country’s vaccine manager, said Monday.
“Regarding Johnson & Johnson, we thank the FDA because its EUA has been released. Now, we have five vaccines with an EUA,” Galvez said in Filipino during a pre-recorded meeting of President Rodrigo Duterte with his Cabinet.
“The only ones left [with an EUA] are Moderna at Novovax,” he added.
The four other vaccines that have secured an EUA are those developed by Sinovac BioTech, AstraZeneca, Pfizer-BioNTech, and Russia’s Gamaleya Institute.
The Philippines has already reserved six million doses of J&J’s single-shot vaccine, Philippine Ambassador to the United States Jose Romualdez previously said.
J&J’s vaccine is said to be 85.4 percent effective in preventing the severe respiratory disease.
The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link .
Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.